NMPA Approval

Hemofiltration Replacement Fluid of Sodium Citrate

Approval Number

国药准字H20253005

Company上海峰林生物科技有限公司

Registration Date

January 2, 2025

Drug Information

Generic Name

枸橼酸钠血滤置换液

Dosage Form

注射剂

Strength

5000ml

Drug Type

化学药品

Registration Date

January 2, 2025

Company Information

Applicant Company

Company Name上海峰林生物科技有限公司

Company Address

上海市闵行区陈行公路2168号11幢701室

Manufacturing Company

Company Name上海长征富民金山制药有限公司

Company Address

上海市金山区金仁路505号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

枸橼酸钠血滤置换液 - NMPA 批准文号 | MedPath